Cellular Senescence in Arterial Diseases
Journal of Lipid and Atherosclerosis · 2020 · 9 (1) · 79
DOI: 10.12997/jla.2020.9.1.79 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Lipid and Atherosclerosis, 2020. Verfasst von Ippei Shimizu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cell-proliferation potency is limited, as cells cannot proceed through the cell cycle continually. Instead, they eventually show an irreversible arrest of proliferation, commonly referred to as cellular senescence. Following the initial discovery of this phenomenon by Hayflick et al., studies have indicated that cells are also destined to undergo aging. In addition to the irreversible termination of proliferation, senescent cells are characterized by a flattened and enlarged morphology. Senescent cells become pro-inflammatory and contribute to the initiation and maintenance of sustained chronic sterile inflammation. Aging is associated with the accumulation of senescent cells in the cardiovascular system, and in general these cells are considered to be pathogenic because they mediate vascular remodeling. Recently, genetic and pharmacological approaches have enabled researchers to eliminate senescent cells both in vitro and in vivo. The term "senolysis" is now used to refer to the depletion of senescent cells, and evidence indicates that senolysis contributes to the reversal of age-related pathogenic phenotypes without the risk of tumorigenesis. The concept of senolysis has opened new avenues in research on aging, and senolysis may be a promising therapeutic approach for combating age-related disorders, including arterial diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
- Division of Molecular Aging and Cell Biology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
- Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development, Tokyo, Japan.
ORCID-Profile: Ippei Shimizu, Tohru Minamino
Zitieren
APA
Shimizu, I., & Minamino, T. (2020). Cellular Senescence in Arterial Diseases. Journal of Lipid and Atherosclerosis, 9(1), 79. https://doi.org/10.12997/jla.2020.9.1.79
Vancouver
Shimizu I, Minamino T. Cellular Senescence in Arterial Diseases. Journal of Lipid and Atherosclerosis. 2020;9(1):79. doi:10.12997/jla.2020.9.1.79
BibTeX
@article{Shimizu2020,
author = {Shimizu, Ippei and Minamino, Tohru},
title = {Cellular Senescence in Arterial Diseases},
journal = {Journal of Lipid and Atherosclerosis},
year = {2020},
volume = {9},
number = {1},
pages = {79},
doi = {10.12997/jla.2020.9.1.79}
}
EUVIMED